Back to Authors

Arroyo, Jeffrey

0009-0001-2022-6360

Mayo Clinic

AltaMed

Citations 2

Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity
Greene, Mallik , Stieber, Brad, Ozbay, A. Burak, Anderson, Joseph, LeMaster, Joseph, Dore, Michael, Stukalin, Igor , Arroyo, Jeffrey , Ebner, Derek W., Karlitz, Jordan J. , Anderson, Joseph C. , Ozbay, A. Burak , Anderson, Joseph, Ebner, Derek W. , Fendrick, A. Mark

Journal of the National Comprehensive Cancer Network | July 9, 2026 | Volume: 24 | Issue: 7 | Pages: No page available

10.6004/jnccn.2026.7015 Get It

Background: Fecal immunochemical tests (FITs), fecal occult blood tests (FOBTs), and multitarget stool DNA (mt-sDNA) tests are convenient, noninvasive colorectal cancer (CRC) screening strategies. However, delays in or failure to complete follow-up colonoscopy (FU-CY) after a positive noninvasive test are associated with higher CRC incidence, complications, and mortality. We sought to evaluate FU-CY rates, time to colonoscopy, and compliance predictors. Patients and Methods: This retrospective cohort study linked 2 data sources: Komodo Health Data with Exact Sciences Laboratories. Data were collected from January 2016 to June 2023 and analyzed in 2024. Study participants (ages 45–75 years) were individuals with positive stool-based CRC screening tests (FIT, guaiac-based FOBT, or mt-sDNA tests). FU-CY compliance was assessed at 30-day intervals up to 365 days, and logistic regression was used to identify predictors of FU-CY. Results: Among 362,646 participants, colonoscopy compliance was 77.1% for mt-sDNA and 45.1% for FIT/FOBT ( P <.001). Overall FU-CY compliance was lowest among Asian and Black populations, but was significantly higher in these subgroups for mt-sDNA versus FIT (Asian: 74.2% vs 41.1%; Black: 71.3% vs 44.6%). The strongest predictor of compliance was use of mt-sDNA (odds ratio, 3.98; P <.001). More than half of participants across all race groups who completed FU-CY after mt-sDNA did so within the first 120 days, whereas none of the FIT/FOBT racial subgroups reached 50% completion within 365 days. Conclusions: Timely completion of colonoscopy after a noninvasive test is critical, as failure to undergo colonoscopy or delays in completion are associated with increased CRC incidence and more advanced-stage disease. These findings demonstrate that mt-sDNA use may help close CRC screening disparity gaps compared with FIT testing. FU-CY adherence is higher, and time to colonoscopy is shorter following a positive mt-sDNA test versus FIT across all racial and ethnic subgroups.
Patient and physician preferences among colorectal cancer screening tests: updated predictions from a discrete choice experiment
Greene, Mallik , Le, Quang A. , LeMaster, Joseph W. , Idriss, Rajab , Arroyo, Jeffrey , Anderson, Joseph , Doré, Michaël , Cutts, Katelyn, Anderson, Joseph C. , Fendrick, A. Mark , Ozbay, A. Burak , Quaife, Matthew , Limburg, Paul J. , Rutten, Lila J. Finney

Current Medical Research and Opinion | October 18, 2025 | Volume: 41 | Issue: 10 | Pages: 1951-1963

10.1080/03007995.2025.2576596 Get It